The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

“Blood-based screening tests are more acceptable to people than colonoscopy and stool tests and likely will increase screening compliance,” said the study’s corresponding author, Dr. William Grady, a ...

A simple blood test could detect colorectal cancer (CRC) with more than 80% accuracy, according to a new study coauthored by researchers at the Fred Hutchinson Cancer Center in Seattle, Washington.

The Food and Drug Administration approved a blood test that can detect colorectal cancer, CBS News reported. It’s called Shield and was developed by Guardant Health Inc. The test was approved by the ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

Doctors recommend screening for this disease starting at age 45.

A new blood test that screens for colorectal cancer has just been approved by the Food and Drug Administration (FDA). The blood sample needed for the new test, called Shield, can be obtained at a ...

A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood test, ...